For many investors, the experimental psychedelics industry may be too risky to invest in. Most companies in this sector are privately held, and psychedelic stocks are often volatile penny or OTC stocks.
Aside from being risky, these stocks can also be difficult to purchase. Most stocks will require you to have a brokerage account that offers access to OTC and international stocks, like Interactive Brokers or TradeStation.
For investors willing to take the risk, the best psychedelic stocks depend on your portfolio and investment goals — while volatility can be ideal for day traders, long-term investors will want to look to stocks with steadier gains over time.
6 popular psychedelic stocks to watch
We round up a selection of stocks in or related to the experimental drug industry, weighting the list more heavily towards popular mid- and large-cap stocks.
The values in this table are accurate as of the market close on March 24, 2026, or the most recent data available. Volume refers to the number of shares traded during the day.
What to look for when investing in psychedelic stock
The experimental drug industry is affected by a range of complex factors such as trade policies, regulations, and fluctuating supply and demand. So when considering psychedelic stocks to buy, it's important that you have access to vital information about a company's financial health, leadership team, and market positioning.
Also keep in mind that, while volatility can be ideal for day traders, long-term investors will want to look for stocks to offer steadier gains over time.
How to invest in psychedelic stock
Research the experimental drug industry. Before investing, learn about the psychedelic stock sector, its trends and the companies within it. Look at each company's financial health, potential for growth and past performance to identify stocks that fit your investment goals.
Choose a stock trading platform. Compare trading fees, access to trading tools and user interface options. We've identified reliable trading platforms to help narrow down your options below or check out the best stock trading apps in Canada to find one that suits your needs.
Open and fund your account. Sign up with your personal details and link a bank account or funding method to deposit money before you start trading.
Select the psychedelic stock(s) to buy. Search by company name or ticker symbol, like CMPS or MMEDF. Compare key metrics such as market cap, price history and earnings per share to pick the best stock for your strategy.
Buy the stock and monitor performance. Place your order to buy the stock and track its performance over time. Consider setting alerts, signing up for industry newsletters or using platform research tools to stay up to date on market changes.
d599fb3a-3477-4063-87f4-1540c26e9cad-Easy to use app
Easy to use app
Easy-to-use platform
Low fees compared to other Big Bank platforms
Wide range of research tools and order types
Discounts for young investors and active traders
Our selection of top picks is based on the same criteria as our annual Stock Trading Platform Awards. This is updated yearly to reflect changes in the market.
"Best for" picks are those we've evaluated to be best for specific product features or categories – you can read our full methodology here. If we show a "Promoted" pick, it's been chosen from among our commercial partners and is based on factors that include special features or offers, and the commission we receive.
This isn't an exhaustive list of all the trading platforms out there. What's best for you depends on your own investing strategy, budget and financial goals.
Are psychedelic stocks a good investment?
While it's possible to turn a profit investing in psychedelic stocks, keep in mind that—like any investment—psychedelic stocks are not immune to risk. These stocks are subject to fluctuating conditions both in the market and in the experimental drug industry, so carefully vet your picks before you invest.
What are the best psychedelic stocks?
A lot of factors go into picking the best psychedelic stocks. Stock performance can be impacted by factors like market conditions, company decisions and global events. Plus, what may be a strong psychedelic stock investment for one person might not be suitable for another.
That said, we rounded up this list of popular psychedelic stocks in or related to the experimental drug industry to help narrow down your options:
Keep in mind that this is not a "best" list or a recommendation. It highlights some psychedelic stocks for informational purposes only and does not indicate past or future performance or investment advice. We do not guarantee any investment performance.
We've outlined detailed company and stock performance details for each psychedelic stock below. Keep reading to decide if any of these companies are the right investment for you.
Compass Pathways Plc (CMPS)
COMPASS Pathways plc operates as a biotechnology company that focuses on mental health in the United Kingdom and the United States. It develops COMP360, a psilocybin therapy, which is in Phase III clinical trial for the treatment of treatment-resistant depression; and is in Phase II clinical trial for treating post-traumatic stress disorder and anorexia nervosa. The company was formerly known as COMPASS Rx Limited and changed its name to COMPASS Pathways plc in August 2020.
Closing stock price
$5.34
Market Capitalization
$606.2 million
Earnings per share (TTM)
-$2.72
52-week stock price range
$2.25
–
$8.90
All dollar amounts in this table are in USD. TTM refers to the "trailing 12 months." All values are accurate as of the market close on March 22, 2026.
Mind Medicine (MindMed) Inc. , a psychedelic medicine biotech company, discovers, develops, and deploys psychedelic inspired medicines and therapies to address addiction and mental illness. The company is assembling a compelling drug development pipeline of innovative treatments based on psychedelic substances, including Psilocybin, LSD, MDMA, DMT, and an Ibogaine derivative, 18-MC.
Market Capitalization
$940.5 million
All dollar amounts in this table are in USD. TTM refers to the "trailing 12 months." All values are accurate as of the market close on March 24, 2026.
Numinus Wellness Inc. provides solutions to develop and deliver psychedelic-assisted psychotherapy and transform the mental health landscape. The company operates in two divisions, Salvation Botanicals and Numinus Health.
Market Capitalization
C$117.8 million
Gross profit (TTM)
C$-81,538
Revenue (TTM)
C$1.5 million
Earnings per share (TTM)
-C$0.11
All dollar amounts in this table are in CAD. TTM refers to the "trailing 12 months." All values are accurate as of the market close on March 24, 2026.
Mindset Pharma Inc. develops and sells psychedelic medicines to treat neurological and psychiatric disorders in Canada. It focuses on developing MSP-1014, a psychedelic drug candidate.
Market Capitalization
C$72.9 million
Gross profit (TTM)
C$3.9 million
Profit margin
-78.82%
Revenue (TTM)
C$7.8 million
Earnings per share (TTM)
-C$0.06
All dollar amounts in this table are in CAD. TTM refers to the "trailing 12 months." All values are accurate as of the market close on March 24, 2026.
Cybin Inc. , a biotechnology company, focuses on developing psychedelic therapeutics to treat various psychiatric and neurological conditions. The company operates through two segments, Serenity Life and Cybin U.
Market Capitalization
$475.5 million
Gross profit (TTM)
$-311,000
Revenue (TTM)
$864,000
Earnings per share (TTM)
-$0.26
All dollar amounts in this table are in USD. TTM refers to the "trailing 12 months." All values are accurate as of the market close on March 24, 2026.
Field Trip Health Ltd. engages in the development and delivery of psychedelic therapies. Its Research division is involved in the development of psychedelic molecules and conducting research on plant-based psychedelics.
Market Capitalization
C$210.8 million
Gross profit (TTM)
C$-8,403
Revenue (TTM)
C$435,460
All dollar amounts in this table are in CAD. TTM refers to the "trailing 12 months." All values are accurate as of the market close on March 24, 2026.
Compare trading platforms to buy psychedelic stock
Compare special offers, low fees and a wide range of investment options among popular trading platforms in Canada. Note that the dollar amounts in the table below are in CAD.
7 of 7 results
Finder Score for stock trading platforms
To make comparing even easier we came up with the Finder Score. Trading costs, account fees and features across 10+ stock trading platforms and apps are all weighted and scaled to produce a score out of 10. The higher the score, the better the platform—it's that simple.
If you're considering adding psychedelic stocks to your portfolio, make sure you thoroughly look into any companies before investing to help mitigate risk. We've compiled a list of psychedelic stocks to help narrow down your options. Then choose a legitimate stock trading platform to start investing. After that it comes down to monitoring the experimental drug industry to know when to buy, sell or hold.
Frequently asked questions about psychedelic stocks
Psychedelic stocks are shares of companies that either directly work in the psychedelic sector or operate within related industries. Investors interested in buying psychedelic stocks may be looking to take advantage of market trends or lock in investments for the long haul.
Unfortunately, it's almost impossible to choose a single "top" psychedelic stock to invest in due to factors like market fluctuations, company management and shifting economic trends. These can all change—sometimes overnight—how a stock performs. It's best to do your own research to decide which companies fit within your risk tolerance. Reviewing a company's financial reports and past stock performance can help you decide if it's worth investing in.
You can keep track of the latest experimental drug news and updates by signing up for financial newsletters, visiting financial news sites, reading company investor relations pages and using market research platforms. Many online brokerages also offer sector reports, stock screeners and alerts to help you track movements in your stock performance or updates in or related to the experimental drug industry.
Sources
Check these other commodities and investment sectors
If you're thinking about diversifying your portfolio and investing in sectors beyond psychedelic stocks, here are some others you can consider:
Important information: Powered by Finder.com. This information is general in nature and is no substitute for professional advice. It does not take into account your personal situation. This information should not be interpreted as an endorsement of futures, stocks, ETFs, CFDs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for most investors. You do not own or have any interest in the underlying asset. Capital is at risk, including the risk of losing more than the amount originally put in, market volatility and liquidity risks. Past performance is no guarantee of future results. Tax on profits may apply. Consider the Product Disclosure Statement and Target Market Determination for the product on the provider's website. Consider your own circumstances, including whether you can afford to take the high risk of losing your money and possess the relevant experience and knowledge. We recommend that you obtain independent advice from a suitably licensed financial advisor before making any trades.
Find out how to invest in the S&P 500 in Canada—one of the world’s most popular stock indices—to diversify your portfolio.
Advertiser disclosure
Finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which Finder receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. Finder compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.
We update our data regularly, but information can change between updates. Confirm details with the provider you're interested in before making a decision.
How likely would you be to recommend Finder to a friend or colleague?
0
1
2
3
4
5
6
7
8
9
10
Very UnlikelyExtremely Likely
Required
Thank you for your feedback.
Our goal is to create the best possible product, and your thoughts, ideas and suggestions play a major role in helping us identify opportunities to improve.